Magnetic Multi-Enzymatic System for Cladribine Manufacturing
Open Access
- 7 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13634
Abstract
Enzyme-mediated processes have proven to be a valuable and sustainable alternative to traditional chemical methods. In this regard, the use of multi-enzymatic systems enables the realization of complex synthetic schemes, while also introducing a number of additional advantages, including the conversion of reversible reactions into irreversible processes, the partial or complete elimination of product inhibition problems, and the minimization of undesirable by-products. In addition, the immobilization of biocatalysts on magnetic supports allows for easy reusability and streamlines the downstream process. Herein we have developed a cascade system for cladribine synthesis based on the sequential action of two magnetic biocatalysts. For that purpose, purine 2′-deoxyribosyltransferase from Leishmania mexicana (LmPDT) and Escherichia coli hypoxanthine phosphoribosyltransferase (EcHPRT) were immobilized onto Ni2+-prechelated magnetic microspheres (MagReSyn®NTA). Among the resulting derivatives, MLmPDT3 (activity: 11,935 IU/gsupport, 63% retained activity, operational conditions: 40 °C and pH 5–7) and MEcHPRT3 (12,840 IU/gsupport, 45% retained activity, operational conditions: pH 5–8 and 40–60 °C) emerge as optimal catalysts for further synthetic application. Moreover, the MLmPDT3/MEcHPRT3 system was biochemically characterized and successfully applied to the one-pot synthesis of cladribine under various conditions. This methodology not only displayed a 1.67-fold improvement in cladribine synthesis (compared to MLmPDT3), but it also implied a practically complete transformation of the undesired by-product into a high-added-value product (90% conversion of Hyp into IMP). Finally, MLmPDT3/MEcHPRT3 was reused for 16 cycles, which displayed a 75% retained activity.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2020-117025RB-I00, 2020/37/K/ST8/03805, LO 2678/2-1)
- Narodowym Centrum Nauki (PID2020-117025RB-I00, 2020/37/K/ST8/03805, LO 2678/2-1)
- Deutsche Forschungsgemeinschaft (PID2020-117025RB-I00, 2020/37/K/ST8/03805, LO 2678/2-1)
This publication has 47 references indexed in Scilit:
- Inhibition of the Escherichia coli 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial AgentsJournal of Medicinal Chemistry, 2013
- Heterofunctional Supports in Enzyme Immobilization: From Traditional Immobilization Protocols to Opportunities in Tuning Enzyme PropertiesBiomacromolecules, 2013
- New insights on nucleoside 2′-deoxyribosyltransferases: a versatile Biocatalyst for one-pot one-step synthesis of nucleoside analogsApplied Microbiology and Biotechnology, 2013
- One-step enzymatic synthesis of nucleosides from low water-soluble purine bases in non-conventional mediaBioresource Technology, 2012
- Enzymatic synthesis of nucleoside analogues using immobilized 2′-deoxyribosyltransferase from Lactobacillus reuteriApplied Microbiology and Biotechnology, 2011
- Biologically important nucleosides: modern trends in biotechnology and applicationMendeleev Communications, 2011
- Sweet and Umami Taste: Natural Products, Their Chemosensory Targets, and BeyondAngewandte Chemie International Edition, 2011
- Cladribine: not just another purine analogue?Expert Opinion on Investigational Drugs, 2009
- Improvement of enzyme activity, stability and selectivity via immobilization techniquesEnzyme and Microbial Technology, 2007
- Crystal structures of free, IMP‐, and GMP‐bound Escherichia coli hypoxanthine phosphoribosyltransferaseProtein Science, 2002